Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Growth Hormones (Jan 2018)

Posted by Matt Breese on Jan 8, 2018

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing

Perspectives on Drug Naming Policies

Posted by Matt Breese on Jan 2, 2018

When it comes time to name your pharmaceutical brand asset, there are important regulations to keep in mind. Gaining approval on a product name can impact your ability to stay on track for a product launch timeline. 
 
In 2017, the FDA published an industry guide on the Nonproprietary Naming of Biological Products. This guide is an excellent resource for pharma leaders.
 
Read More

Topics: Branding & Marketing

MMIT Reality Check on Diabetes (Dec 2017)

Posted by Matt Breese on Dec 31, 2017

According to our recent payer coverage analysis for type 2 diabetes treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Which Disease Areas Are On Your Mind Going Into 2018?

Posted by Matt Breese on Dec 31, 2017

We reviewed activity across major disease areas featured in 2017 MMIT Reality Checks and gathered poll data from pharma brand teams to understand where the biggest buzz is within market access. The following disease areas (in order) is where we received the most interest - some of these surprised us...

Read More

Topics: Specialty, Industry Trends, Market Access, Branding & Marketing

MMIT Reality Check on Hemophilia (Dec 2017)

Posted by Matt Breese on Dec 20, 2017

According to our recent payer coverage analysis for hemophilia treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Perspectives on Marketing to Millennials

Posted by Matt Breese on Dec 12, 2017

Many younger millennials have never had their own health insurance coverage and don’t understand how health insurance works. Carriers must explain how their plans work and emphasize values beyond medical services to get millennials to enroll in health plans and stay enrolled.
 
For example, nutrition programs such as BlueShield's HealthyLife Rewards emphasize and reward their subscribers for healthy eating habits. 
 
Read More

Topics: Payer, Branding & Marketing

MMIT Reality Check on Multiple Sclerosis (Nov 2017)

Posted by Matt Breese on Nov 30, 2017

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

MMIT Reality Check on G-CSF (Nov 2017)

Posted by Matt Breese on Nov 19, 2017

According to our recent payer coverage analysis for G-CSF treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Perspectives on Twitter Marketing

Posted by Matt Breese on Nov 14, 2017

If you follow social media trends, you've likely heard the news that Twitter recently increased its messaging limit to 280 characters. The Twitter product team made this change after noticing that 9% of English-language Tweets included exactly 140 characters, indicating that many users were editing the length of their messages.

What does this tech change have to do with pharma? This modification can help pharma marketers make sure their messages are compliant with FDA guidelines, according to Andrew Grojean, Social Media Manager at Intouch Solutions

Read More

Topics: Industry Trends, Branding & Marketing

MMIT Reality Check on Heart Failure (Nov 2017)

Posted by Matt Breese on Nov 7, 2017

According to our recent payer coverage analysis for chronic heart failure treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing